Viyash Scientific Limited (BOM:512529)
India · Delayed Price · Currency is INR 259.85
+8.85 (3.53%)
At close: Jul 27, 2026
Viyash Scientific Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 34,203 | 34,203 | 30,068 | 13,697 | 14,209 | 14,128 |
Revenue Growth | 13.75% | 13.75% | 119.52% | -3.60% | 0.57% | 3.76% |
Gross Profit Gross Profit Growth | 17,697 | 17,697 | 14,526 | 5,845 | 5,628 | 5,979 |
Operating Income Operating Income Growth | 4,206 | 4,206 | 1,536 | 232.73 | -153.46 | 579.62 |
Net Income Net Income Growth | 1,773 | 1,773 | 232.19 | -358.69 | -1,212 | 409.55 |
Earnings Per Share EPS Growth | 4.01 | 4.01 | 0.53 | -1.44 | -4.88 | 1.63 |
EPS Growth | 656.61% | 656.61% | - | - | - | -57.66% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
India India Growth | 9,068 | 9,068 | 8,237 | - | - | - |
USA USA Growth | 4,882 | 4,882 | 4,287 | - | - | - |
Spain Spain Growth | 3,656 | 3,656 | 2,806 | - | - | - |
Rest of the World Rest of the World Growth | 16,596 | 16,596 | 14,738 | 4,680 | 3,690 | 4,286 |
Total Total Growth | 34,203 | 34,203 | 30,068 | 13,697 | 14,209 | 14,128 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 2,594 | 2,594 | 1,469 | 674.23 | 416.2 | 589.33 |
Total Debt Total Debt Growth | 4,898 | 4,898 | 6,543 | 4,877 | 4,436 | 3,649 |
Net Cash (Debt) Net Cash Growth | -2,303 | -2,303 | -5,074 | -4,203 | -4,020 | -3,060 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -5.21 | -5.21 | -11.64 | -16.82 | -16.18 | -12.20 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 3,229 | 3,229 | 3,448 | 305.95 | 168.08 | 305.95 |
Capital Expenditures CapEx Growth | -1,347 | -1,347 | -1,081 | -308.07 | -861.79 | -324.64 |
Free Cash Flow Free Cash Flow Growth | 1,882 | 1,882 | 2,367 | -2.12 | -693.71 | -18.69 |
Free Cash Flow Growth | -20.51% | -20.51% | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 51.74% | 51.74% | 48.31% | 42.67% | 39.61% | 42.32% |
Operating Margin | 12.30% | 12.30% | 5.11% | 1.70% | -1.08% | 4.10% |
Pretax Margin | 10.20% | 10.20% | 0.44% | -3.99% | -9.69% | 3.75% |
Profit Margin | 5.18% | 5.18% | 0.77% | -2.62% | -8.53% | 2.90% |
FCF Margin | 5.50% | 5.50% | 7.87% | -0.01% | -4.88% | -0.13% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 64.80 | 45.10 | 140.77 | - | - | 80.66 |
Forward PE | 27.94 | 19.59 | 26.97 | 26.97 | 26.97 | 50.49 |
P/FCF Ratio | 60.27 | 42.49 | 13.81 | - | - | - |
PS Ratio | 3.32 | 2.34 | 1.09 | 2.09 | 1.27 | 2.34 |